Clostridium difficile - Setting the scene

Journal of Antimicrobial Chemotherapy

Volumn 41, Issue SUPPL. C, 1998, Pages 1-3

  Wilcox, Mark H ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

CLOSTRIDIUM DIFFICILE; COLITIS; EDITORIAL; HEALTH CARE COST; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; MORBIDITY; MORTALITY; REGISTER;

EID: 0031972193     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/41.suppl_3.1     Document Type: Editorial

References (18)

1. Larson, H. E., Price, A. B., Honour, P. & Borriello, S. P. (1978). Clostridium difficile and the aetiology of pseudomembranous colitis. Lancet i, 1063-6.
2. Bartlett, J. G., Chang, T. W., Gurwith, M., Gorbach, S. L. & Onderdonk, A. B. (1978). Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. New England Journal of Medicine 298, 531-4.
3. Wilcox, M. H. (1996). Cleaning up Clostridium difficile infection. Lancet 348, 767-8.
4. Tabaqchali, S. & Jumaa, P. (1995). Diagnosis and management of Clostridium difficile infection. British Medical Journal 310, 1375-80.
5. Kelly, C. P., Pothoulakis, C. & LaMont, J. T. (1994). Clostridium difficile colitis. New England Journal of Medicine 330, 257-62.
6. Communicable Disease Surveillance Centre. (1997). Clostridium difficile in England and Wales: quarterly report. Communicable Disease Report Weekly 7, 412.
7. Wilcox, M. H. & Smyth, E. T. M. (1997). UK survey of the incidence and impact of Clostridium difficile infection 1993-96. In Programme of the Third Federation of Infection Societies Conference, Manchester, 1997. Abstract P20.
8. Plowman, R. M., Graves, N. & Roberts, J. A. (1997). Hospital-acquired Infection. Office of Health Economics. BSC Print, London.
9. Murray, I. (1995). Hospital infections kill thousands. The Times (London), 16 September 1997, p. 4.
10. Hospital Infection Working Group of the Department of Health and Public Health Laboratory Service. (1995). Hospital Infection Control. Guidance on the Control of Infection in Hospitals. Department of Health, London.
11. Wilcox, M. H., Cunniffe, J. G., Trundle, C. & Redpath, C. (1996). Financial burden of hospital-acquired Clostridum difficile infection. Journal of Hospital Infection 34, 23-30.
12. Starr, J. M., Rogers, T. R. & Impallomeni, M. (1997). Hospital-acquired Clostridium difficile diarrhoea and herd immunity. Lancet 349, 426-8.
13. O'Neill, G. L., Brazier, J. S., Magee, J. T. & Duerden, B. I. (1996). A comparison of PCR ribotyping and pyrolysis mass spectrometry for typing clinical isolates of Clostridium difficile. Anaerobe 2, 211-5.
14. Warny, M., Vaerman, J. P., Avesani, V. & Delmée, M. (1994). Human antibody response to Clostridium difficile toxin A in relation to clinical course of infection. Infection and Immunity 62, 384-9.
15. Bacon, A. E. & Fekety, R. (1994). Immunoglobulin G directed against toxins A and B of Clostridium difficile in the general population and patients with antibiotic-associated diarrhea. Diagnostic Microbiology and Infectious Disease 18, 205-9.
16. Johnson, S., Gerding, D. N. & Janoff, E. N. (1992). Systemic and mucosal antibody responses to toxin A in patients infected with Clostridium difficile. Journal of Infectious Diseases 166, 1287-94.
17. Office of Population Census and Statistics. (1991). Population Trends 51 and Monitor PP2 91/1. OPCS, London.
18. Department of Health and Public Health Laboratory Service Joint Working Group. (1994). Clostridium difficile Infection. Prevention and Management. BAPS, Lancashire.